Overview

Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

Status:
Withdrawn
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effect of BMS-823778 on reducing atherosclerotic plaque inflammation
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb